These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25395300)

  • 1. Chemokine decoy receptor D6 mimicking trap (D6MT) prevents allosensitization and immune rejection in murine corneal allograft model.
    Choi W; Byun YJ; Jung E; Noh H; Hajrasouliha AR; Sadrai Z; Chang E; Lee JH; Lee HK
    J Leukoc Biol; 2015 Feb; 97(2):413-24. PubMed ID: 25395300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection.
    Hajrasouliha AR; Sadrai Z; Lee HK; Chauhan SK; Dana R
    Mol Vis; 2013; 19():2517-25. PubMed ID: 24357920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.
    Hamrah P; Yamagami S; Liu Y; Zhang Q; Vora SS; Lu B; Gerard CJ; Dana MR
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1228-36. PubMed ID: 17325167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft rejection: examination of the expression and function of the decoy chemokine receptor D6.
    Bradford L; Marshall H; Robertson H; Kirby JA; Graham G; Ali S; O'Boyle G
    Transplantation; 2010 Jun; 89(11):1411-6. PubMed ID: 20404785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants.
    Qian Y; Dekaris I; Yamagami S; Dana MR
    Arch Ophthalmol; 2000 Dec; 118(12):1666-71. PubMed ID: 11115261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential chemokine gene expression in corneal transplant rejection.
    Yamagami S; Miyazaki D; Ono SJ; Dana MR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2892-7. PubMed ID: 10549649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of macrophage phenotype in rejected corneal allografts.
    Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
    Solomon MF; Kuziel WA; Simeonovic CJ
    Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
    Pillai RG; Beutelspacher SC; Larkin DF; George AJ
    Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.
    Sugaya S; Chen WS; Cao Z; Kenyon KR; Yamaguchi T; Omoto M; Hamrah P; Panjwani N
    Cornea; 2015 Jun; 34(6):675-681. PubMed ID: 25961492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
    Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
    Torres PF; Slegers TP; Peek R; van Rooijen N; van der Gaag R; Kijlstra A; de Vos AF
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3194-201. PubMed ID: 10586942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
    Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R
    Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of stromal cell-derived factor-1 and CXC chemokine receptor 4 in corneal graft rejection in rats].
    Wu XS; Wu J; Ma M; Lu XL; Yu J; Zhang ZY
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1677-1683. PubMed ID: 27998864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
    Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
    Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node removal enhances corneal graft survival in mice at high risk of rejection.
    Plsková J; Holán V; Filipec M; Forrester JV
    BMC Ophthalmol; 2004 Mar; 4():3. PubMed ID: 15038832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.